Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
98215
Q100: Staff unique ID 3 (q100id3)
Data file: p_do_1
Overview
Valid:
276
Invalid:
0
Type:
Discrete
Start:
1301
End:
1305
Width:
5
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ER 02 | 2 |
0.7%
|
|
| ER 09 | 1 |
0.4%
|
|
| ER 11 | 1 |
0.4%
|
|
| ER 13 | 5 |
1.8%
|
|
| ER 14 | 1 |
0.4%
|
|
| ER 29 | 1 |
0.4%
|
|
| ER 3 | 1 |
0.4%
|
|
| ER 59 | 1 |
0.4%
|
|
| ER 71 | 1 |
0.4%
|
|
| ER 74 | 1 |
0.4%
|
|
| ER03 | 1 |
0.4%
|
|
| ER08 | 1 |
0.4%
|
|
| ER11 | 4 |
1.4%
|
|
| ER14 | 2 |
0.7%
|
|
| ER15 | 1 |
0.4%
|
|
| ER16 | 1 |
0.4%
|
|
| ER18 | 2 |
0.7%
|
|
| ER19 | 1 |
0.4%
|
|
| ER20 | 2 |
0.7%
|
|
| ER21 | 3 |
1.1%
|
|
| ER23 | 2 |
0.7%
|
|
| ER25 | 3 |
1.1%
|
|
| ER27 | 3 |
1.1%
|
|
| ER3 | 3 |
1.1%
|
|
| ER30 | 1 |
0.4%
|
|
| ER34 | 2 |
0.7%
|
|
| ER46 | 1 |
0.4%
|
|
| ER5 | 4 |
1.4%
|
|
| ER8 | 1 |
0.4%
|
|
| GN | 1 |
0.4%
|
|
| GN12 | 2 |
0.7%
|
|
| GN26 | 1 |
0.4%
|
|
| GN27 | 6 |
2.2%
|
|
| GN30 | 3 |
1.1%
|
|
| GN32 | 3 |
1.1%
|
|
| GN33 | 2 |
0.7%
|
|
| GN35 | 6 |
2.2%
|
|
| GN45 | 9 |
3.3%
|
|
| GN72 | 22 |
8%
|
|
| OB 06 | 1 |
0.4%
|
|
| PE 07 | 1 |
0.4%
|
|
| PE-27 | 1 |
0.4%
|
|
| PE01 | 4 |
1.4%
|
|
| PE02 | 1 |
0.4%
|
|
| PE03 | 3 |
1.1%
|
|
| PE04 | 4 |
1.4%
|
|
| PE05 | 1 |
0.4%
|
|
| PE06 | 20 |
7.2%
|
|
| PE07 | 2 |
0.7%
|
|
| PE08 | 10 |
3.6%
|
|
| PE09 | 4 |
1.4%
|
|
| PE1 | 13 |
4.7%
|
|
| PE10 | 5 |
1.8%
|
|
| PE11 | 3 |
1.1%
|
|
| PE12 | 1 |
0.4%
|
|
| PE13 | 1 |
0.4%
|
|
| PE14 | 5 |
1.8%
|
|
| PE15 | 7 |
2.5%
|
|
| PE16 | 1 |
0.4%
|
|
| PE18 | 1 |
0.4%
|
|
| PE20 | 7 |
2.5%
|
|
| PE21 | 7 |
2.5%
|
|
| PE23 | 7 |
2.5%
|
|
| PE28 | 2 |
0.7%
|
|
| PE31 | 1 |
0.4%
|
|
| PE32 | 1 |
0.4%
|
|
| PE33 | 8 |
2.9%
|
|
| PE35 | 2 |
0.7%
|
|
| PE36 | 4 |
1.4%
|
|
| PE37 | 12 |
4.3%
|
|
| PE38 | 2 |
0.7%
|
|
| PE39 | 2 |
0.7%
|
|
| PE43 | 1 |
0.4%
|
|
| PE50 | 3 |
1.1%
|
|
| PE51 | 3 |
1.1%
|
|
| PE53 | 8 |
2.9%
|
|
| PE55 | 1 |
0.4%
|
|
| SU05 | 6 |
2.2%
|
|
| SU09 | 1 |
0.4%
|
|
| SU12 | 1 |
0.4%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.